Indrayani Biotech’s arm acquires 51% stake in HIPL

08 Dec 2022 Evaluate

Indrayani Biotech’s wholly owned subsidiary -- IBL Healthcare has acquired 5,10,000 equity shares, constituting 51% of total no of equity shares, of Healthway India (HIPL). Thus, HIPL has become a subsidiary company of IBL Healthcare. The cost of acquisition is Rs 5.10 lakh.

Indrayani Biotech is a company belonging to food sector. They are a part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company also markets and distributes hybrid vegetable seeds manufactured by Hoechst India. It plans to produce these seeds for Hoechst in due course of time.

Indrayani Biotech Share Price

42.37 0.27 (0.64%)
14-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Indrayani Biotech 42.37
SIP Industries 6.01
Trescon 15.90
Jayasilpa Floritech
Farmtek Agro Exports
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.